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To date, limited knowledge exists regarding the role of the androgen signaling during specific periods of development in the
regulation of androgen receptor (AR) and connexin 43 (Cx43) in adult prostate. Therefore, in this study we examined mRNA
and protein expression, and tissue distribution of AR and Cx43 in adult boar prostates following fetal (GD20), neonatal (PD2),
and prepubertal (PD90) exposure to an antiandrogen flutamide (50mg/kgbw). In GD20 and PD2 males we found the reduction
of the luminal compartment, inflammatory changes, decreased AR and increased Cx43 expression, and altered localization of both
proteins. Moreover, enhanced apoptosis and reduced proliferation were detected in the prostates of these animals. In PD90 males
the alterations were less evident, except that Cx43 expression was markedly upregulated. The results presented herein indicate that
in boar androgen action during early fetal and neonatal periods plays a key role in the maintenance of normal phenotype and
functions of prostatic cells at adulthood. Furthermore, we demonstrated that modulation of Cx43 expression in the prostate could
serve as a sensitive marker of hormonal disruption during different developmental stages.
1. Introduction
The prostate, an accessory gland of the male urogeni-
tal system, is under strict control by testicular hormones
and androgens. Androgens, apart from maintaining tissue
homeostasis and controlling secretory function of prostatic
epithelium, play a major role in the regulation of prostate
development and differentiation before birth and during
puberty. The majority of the effects of androgens are medi-
a t e db yt h ea n d r o g e nr e c e p t o r( A R ) ,am e m b e ro fl i g a n d -
activated nuclear receptors family [1]. Inactivating mutations
of the AR or exposure to high doses of AR antagonists
during in utero development have been shown to severely
compromise prostate growth and differentiation, resulting in
i t sc o m p l e t ea g e n e s i so rm a r k e dd e c r e a s ei np r o s t a t ew e i g h t
at birth [2–4]. On the other hand, transient disruption of
androgen action during some specific periods of fetal or
postnatal development induces functional alterations that
may not be manifested until puberty or afterwards [5–7].
For example, gestational exposure of rats to an antiandrogen,
vinclozolin,duringgonadalsexdeterminationresultsinadult
onset disease of the prostate. Prepubertal rats showed no
abnormalitiesinventralprostatemorphology,whereasinthe
older animals regression of prostatic secretory epithelium,
cystic hyperplasia, and focal prostatitis were detected [5, 6].
Recentstudiesfromthislaboratoryshowedthattransient
fetal, neonatal, or prepubertal exposure to an antiandrogen
flutamide leads to adverse effects on the morphology and
hormonalfunctionsofthetestisandepididymisofadultboar.
Furthermore, these alterations were associated with changes
in the expression and distribution of intercellular junction
proteins, including gap junction protein connexin 43 (Cx43)
[8–10].
Cx43 belongs to the multigene connexin family that
consists of at least 21 members in humans [11]. In the
plasma membrane of two neighboring cells connexin protein2 BioMed Research International
subunits form hemichannels called connexons. Gap junction
channels are composed of two identical (homotypic) or
different(heterotypic)connexonsandallowadirectexchange
of small molecules (<1kDa) such as nucleotides, second
messengers, peptides, and ions between the cells [12]. Recent
findings have demonstrated that gap junctions composed of
Cx43 have an essential role in the regulation of cell adhesion,
proliferation, differentiation, homeostasis, and oncogenic
transformation in male reproductive system [13].
Studies in rodents showed that in the prostate different
types of cells communicate via gap junctions composed of
different connexins. During early steps of postnatal develop-
ment Cx43 expression is strong in periurethral mesenchymal
c e l l sa n du n d i ff e r e n t i a t e de p i t h e l i a lc e l l s .A st h ep r o c e s so f
morphogenesiscontinues,Cx43expressiondeclines,whereas
Cx32 expression increases concomitantly with an increase in
the differentiated secretory cell population. Finally, in the rat
adultprostatetheexpressionofCx32isrestrictedtosecretory
epithelial cells, whereas basal epithelial cells express Cx43
[14, 15]. Dysregulation of these Cxs expression, especially of
C x 4 3 ,i st h o u g h tt op l a yar o l ei nc a r c i n o g e n e s i s[ 16, 17].
Although it was reported that the Cx43 expression, traf-
ficking, and assembly in the prostatic cells are influenced by
the androgens, limited knowledge exists regarding role of the
androgen signaling during specific periods of prenatal and
postnatal development on their expression in adult prostate.
Therefore, in this study we examined Cx43 expression and
distribution in adult pig prostate following fetal, neonatal,
and prepubertal exposure to flutamide. Moreover, to answer
the question whether androgen signal was altered in the
adultboarprostates,theexpressionofandrogenreceptorwas
evaluated.Inaddition,theeffectofantiandrogenonprostatic
tissue morphology, apoptosis, and proliferation of prostatic
cells was analyzed.
2. Material and Methods
2.1. Animals and Experimental Design. Sexually mature
boars (Large White × Polish Landrace) originating from five
litters were allotted into four groups (𝑛=3each group). First
group of experimental animals was exposed from day 20
to 28 of gestation (GD20) to an antiandrogen flutamide (2-
methyl-N-[4-nitro-3-(trifluoromethyl)-phenyl]propamide;
Sigma-Aldrich, St Louis, MO, USA). Next two groups were
injected with flutamide postnatally on days 2–10 (PD2) or
on days 90–98 (PD90) after birth. Flutamide was suspended
in corn oil and administered subcutaneously in five doses
(50mg/kgbodyweight)everyseconddaytoantagonizetesto-
steroneactionwithoutproducingatoxiceffectinthesowand
neonates[3].Thelastgroupincludedcontrolanimalsforeach
experimental group. Control boars were given a vehicle only
(cornoil).Thetimeofexposuretoflutamidewasbasedonthe
literature and our own data described previously [10, 18, 19].
Briefly, in utero exposure to flutamide included the period
of embryonic gonadal sex determination, whereas postnatal
exposures included the periods of neonatal and prepubertal
development [20, 21]. Both control and experimental
animals were maintained under identical conditions, with
ad libitum feeding and water until 9 months of age when
they were slaughtered and prostates were removed. All
surgical procedures were performed by a veterinarian and
followed approved guidelines for the ethical treatment of
animals in accordance with the Polish legal requirements
under the license given by the Local Ethics Committee at the
Jagiellonian University in Krakow (no. 34/2008).
2.2. Tissue Preparation. Tissue samples were fixed by immer-
sion in 4% formaldehyde freshly prepared from paraform-
aldehydeanddehydratedinanincreasinggradientofethanol,
cleared in xylene, and embedded in paraplast (Sigma-
Aldrich) for immunohistochemistry. Sections of 5𝜇mi n
thickness were mounted on slides coated with 3-aminopro-
pyltriethoxysilane(Sigma-Aldrich),deparaffinized,andrehy-
drated through decreasing alcoholic solutions. Other tissue
fragments were immediately frozen in a liquid nitrogen and
stored at −80
∘C for RNA isolation and protein extraction.
2.3.RNAIsolation,ReverseTranscription,andRT-PCR. Total
RNA was extracted from prostates using TRIzol reagent
(LifeTechnologies,Gaithersburg,MD,USA)accordingtothe
manufacturer’s instruction. To remove residual DNA con-
tamination, the RNA samples were incubated with RNAase-
free DNAse (Promega, Madison, WI, USA) at 37
∘Cf o r1 5
minutes. The yield and quality of the RNA was assessed by
measuring the 𝐴260 :𝐴 280 ratio in a spectrophotometer
(NanoDrop 2000, Thermo Scientific, Wilmington, DF, USA)
and by electrophoresis.
The purified total RNA was used to generate cDNA. A
volume equivalent to 1𝜇go ft o t a lR N Aw a sr e v e r s et r a n -
scribed using High-Capacity cDNA Reverse Transcription
Kit (Applied Biosystems, Carlsbad, CA, USA) according to
the manufacturer’s protocol. cDNA was prepared in a 20𝜇L
volume using the random primers, dNTP mix, RNAse inhi-
bitor, and reverse transcriptase (RT). Parallel reactions for
eachRNAsamplewererunintheabsenceofRTtoassessany
genomic DNA contamination. 1𝜇Lo fR N a s e - f r e ew a t e rw a s
added in place of RT.
The cDNA samples were then subjected to PCR ampli-
fication performed in a Veriti thermal cycler (Applied Bio-
systems) with a temperature cycling program of 10min at
25
∘C, 2h at 37
∘C, and 5min at 85
∘C. Samples were kept at
−20
∘C until further analysis. PCR reactions were performed
with reaction mixture containing 1𝜇Lo fc D N A ,1 0𝜇M
forward and reverse primers obtained from Institute of Bio-
chemistry and Biophysics PAS (Warsaw, Poland), 10mM of
dinucleotide triphosphate, 10x PCR buffer, and 2 units of
DyNAzyme II polymerase (Finnzymes, Espoo, Finland) in
a Veriti thermal cycler. The primer sequences used for PCR
amplifications were as follows: for AR, forward (5
򸀠-CAC-
ATTGAAGGCTATGAGTG-3
򸀠)a n dr e v e r s e( 5
򸀠-CCCATC-
CAGGAGTACTGAAT-3
򸀠)[ 22]; for Cx43, forward (5
򸀠-GGT
GGA CTG TTT CCT CTC TCG-3
򸀠)a n dr e v e r s e( 5
򸀠-GGA
GCA GCC ATT GAA ATA AGC-3
򸀠);andforglyceraldehyde-
3-phosphate dehydrogenase (GADPH) forward (5
򸀠-GGA
C T CA T GA C CA C GG T CC A T - 3
򸀠)a n dr e v e r s e( 5
򸀠-TCA
GAT CCA CAA CCG ACA CGT-3
򸀠)[ 23]. GAPDH was usedBioMed Research International 3
as an internal control. No-RT controls were performed for
eachRNAsampleandno-templatecontrolswereincludedon
each PCR plate.
Three independent experiments were performed. All
P C Rp r o d u c t sw e r ea n a l y z e db ye l e c t r o p h o r e s i so n1 . 5 – 2 . 5 %
agarose gels with ethidium bromide together with a ready-
load 100bp DNA ladder marker (Promega) and followed by
fluorescencedigitizationusingaBio-RadGelDocXRsystem
(Bio-Rad Labs., Hercules, CA, USA).
2.4. Real-Time Quantitative RT-PCR. Real-time RT-PCR
analyses were performed using the StepOne Real-Time PCR
system (Applied Biosystems) with the same cDNA templates
as described above. The mRNA expression levels of the AR
andCx43werequantifiedineachsampleusingTaqManGene
Expression Assays (Applied Biosystems) as follows: for AR
assay ID, Ss03822350 s1; for Cx43 assay ID, Ss03374839 u1.
GAPDH levels were determined as an endogenous control
assay(AppliedBiosystems,assayID,Ss03375629 u1).Quanti-
tativePCRwasperformedwith200ngofcDNA,1𝜇LTaqMan
PCR master mix (Applied Biosystems) in a final volume of
20𝜇L. After 2min of incubation at 50
∘C, the thermal cycling
conditions were 10min at 95
∘Cf o l l o w e db y4 0r e p e a t so f
15sec at 95
∘Ca n d1m i na t6 0
∘C. To monitor DNA contam-
ination, control reactions without the RNA template were
performed in triplicate and one reaction without the reverse
transcriptase enzyme was carried out per tissue sample.
Relative quantification (RQ) was obtained using the
2
−ΔΔCt method, adjusting the AR and Cx43 mRNAs expres-
sion to the expression of GAPDH mRNA and taking the
adjusted expression in the control group as reference (RQ =
1)[24].Threeindependentexperimentswereperformed,each
in triplicate with tissues prepared from different animals.
2.5. Western Blot Analysis. Prostate fragments of control and
flutamide-treated boars were homogenized on ice with a
coldRIPAbuffer(Sigma-Aldrich),sonicated,andcentrifuged
at 10,000×gf o r2 0m i na t4
∘C as described previously [8].
Additionally, homogenates of prostates from prepubertally
castratedpigs(𝑛=3 )wereusedaspositivecontrolsforPCNA
and cleaved caspase 3 analyses. Aliquots were assayed for
proteinbytheBradforddye-bindingprocedurewithBSAasa
standard[25].Thereafter,25𝜇gofproteinwassolubilizedina
sample buffer (Bio-Rad Labs.) and heated at 99.9
∘Cfor5min.
Afterdenaturation,proteinswereseparatedbysodiumdode-
c y ls u l f a t ep o l y a c r y l a m i d eg e le l e c t r o p h o r e s i s( S D S - P A G E )
in 10% (vol/vol) resolving gels under reducing conditions.
Separated proteins were transferred onto polyvinylidene
difluoride membranes (Merck Millipore, Darmstadt, Ger-
m a n y )u s i n gaw e tb l o t t e ri nt h eG e n i eT r a n s f e rB u ff e r( p H
8.4) for 90min at a constant current of 250mA. Nonspecific
binding sites were blocked with a solution of nonfat dry
milk (5%, wt/vol) containing 0.1% Tween 20 (vol/vol), and
t h em e m b r a n ew a si n c u b a t e di nr a b b i tp o l y c l o n a la n t i b o d y
against AR (1:5000; Santa Cruz Biotechnology, Santa Cruz,
CA, USA), rabbit polyclonal antibody against Cx43 (1:4000;
Sigma-Aldrich), rabbit polyclonal antibody against caspase
3 (1:1000; Cell Signaling Technology, Beverly, MA, USA),
and mouse monoclonal antibody against PCNA (1:500;
Merck Millipore) for 2h at room temperature. Thereafter, the
membraneswerewashedbrieflywithTBST(0.05MTris-HCl,
0.15M NaCl, 0.1% Tween 20, pH 7.6) and incubated in a goat
anti-mouseorgoatanti-rabbitIgG linkedto thehorseradish-
peroxidase (1:3000; Vector Lab., Burlingame, CA, USA)
for 1h at room temperature. Immunoreactive proteins were
detectedbychemiluminescencewithWesternBlottingLumi-
nol Reagent (Santa Cruz Biotechnology), and images were
capturedwithaChemiDocXRS+System(Bio-RadLabs.).All
immunoblots were stripped with stripping buffer containing
62.5mMTris-HCL,100mM2-mercaptoethanol,and2%SDS
(wt/vol) (pH 6.7) at 50
∘Cf o r3 0m i na n di n c u b a t e di nr a b b i t
polyclonalantibodyagainst𝗽-actin(dilution,1:3000;Sigma-
Aldrich) which served as a loading control. Each data point
was normalized against its corresponding actin data point.
Molecular masses were estimated by reference to standard
proteins (Fermentas, GmbH, St. Leon-Rot, Germany). To
obtainquantitativeresults,immunoblotswereanalyzedusing
Image Lab 2.0 (Bio-Rad Labs.).
2.6. Morphological and Histomorphometrical Analysis. Hem-
atoxylin and eosin staining of paraffin-embedded prostates
wasperformedbyaroutineprotocol.Morphologicalanalyses
wereperformedonNikonEclipseNimicroscope(NikonCo.,
Tokyo, Japan), and the microscopic fields were digitized.
The microscope with a ×10 ocular and a ×20 objec-
tive was used for the histomorphometrical measurements.
Detailed analyses were performed on random images of 30
histological fields per experimental group with the use of
NIS-Elements Microscope Imaging Software (Nikon Co.).
Epithelium height, as well as the area of luminal, epithelial,
and stromal compartment was measured, and relative pro-
portions among the prostate components were calculated.
2.7. Immunohistochemistry and Immunofluorescence. Pros-
tate sections were cleared in xylene and rehydrated in a series
of ethanol grade. To achieve antigen retrieval the slices were
immersed in 10mM citrate buffer (pH 6.0) and heated for
8min in the microwave oven (750W).
For AR and Cx43 immunostaining, endogenous per-
oxidase activity was neutralized with methanol containing
0.3% H2O2 for10minwhereasnonspecificbindingsiteswere
blocked with 10% nonimmune goat or horse serum (vol/vol)
for 30min at room temperature. Then, prostate sections were
incubated overnight at 4
∘C in a humidified chamber with
appropriate primary antibody: rabbit polyclonal antibody
against AR (1:250; Santa Cruz Biotechnology), or rabbit
polyclonal antibody against Cx43 (1:50; Sigma-Aldrich).
Next, biotinylated secondary antibody, goat anti-rabbit IgG
( 1 : 4 0 0 ;V e c t o rL a b . ) ,w a sa p p l i e df o r6 0 m i n .A ft e re a c h
step in these procedures, sections were carefully rinsed with
Tris-buffered saline (TBS; 0.05M Tris-HCl, 0.15M NaCl, pH
7.6); the antibodies were also diluted in TBS buffer. The
stainingwasdevelopedusingavidin-biotinylatedhorseradish
peroxidase complex (ABC/HRP; 1:100; VECTASTAIN Elite
ABC Reagent, Vector Lab.) for 30min followed by 0.05%
3.3
򸀠-diaminobenzidine tetrachloride (DAB; Sigma-Aldrich)4 BioMed Research International
Table 1: Morphometric analyses of prostate sections from control and flutamide-treated boars (𝑛=3 0fields/group).
Control GD20 PD2 PD90
Epithelial compartment (%) 73.44 ± 4.43 79.45 ± 7.91 82.77 ± 5.36 63.13 ± 4.34
Luminal compartment (%) 17.17 ± 3.11 5.07 ± 0.34
∗∗ 5.41 ± 1.35
∗∗ 22.25 ± 4.42
Stromal compartment (%) 9.39 ± 1.46 15.27 ± 7.90 11.61 ± 4.34 14.62 ± 1.48
Epithelium height (𝜇m) 15.35 ± 2.80 13.12 ± 2.14 14.25 ± 2.22 14.51 ± 4.15
Data are expressed as means ± SD. Significant differences from control values are denoted as ∗∗P < 0.01.
in TBS containing 0.01% H2O2 and 0.07% imidazole for
6min. Thereafter, sections were washed, slightly counter-
stained with Mayer’s hematoxylin, dehydrated, and mounted
using DPX mounting media (Sigma-Aldrich). All slides were
processed immunohistochemically at the same time with the
same treatment so that staining intensity among different
sectionsofthepr osta tecouldbecom par ed.N ega tivecon tr ols
included sections incubated with 10% nonimmune goat or
horse serum instead of primary antibody. All immunohisto-
chemical experiments were repeated three times. Immuno-
histochemistry for AR and Cx43 was also performed using
NovoLink Polymer Detection System (Novocastra Labs.,
Newcastle upon Tyne, UK), according to the manufacturer’s
instructions. Afterwards, sections were examined with a
Leica DMR microscope (Leica Microsystems, Wetzlar, Ger-
many)usingNomarskiinterferencecontrast.Sincetherewere
no differences in the staining localization and intensities
between both methods used, only the results obtained by
the former technique (ABC method) were presented and
discussed below.
ForPCNAimmunofluorescence,sectionswerefirstincu-
bated overnight at 4
∘Ci nah u m i d i fi e dc h a m b e rw i t hm o u s e
monoclonal antibody against PCNA, clone PC-10 (1:1000;
Merck Millipore). After being rinsed in TBST, the sections
were incubated with fluorescent Alexa Fluor 488 goat anti-
mouse antibody (Invitrogen, Carlsbad, CA, USA) at 1:100
dilution for 1.5h in the dark. Finally, the slides were mounted
in Vectashield medium for fluorescence with 4
򸀠6-diamidino-
2-phenylindole (DAPI; Vector Labs.) and viewed under a
ZeissconfocallaserscanningmicroscopeLSM510(CarlZeiss
GmbH, Jena, Germany).
2.8. Qualitative and Quantitative Evaluation of the Immuno-
histochemical Reactions. Immunohistochemical staining for
both antigens, Cx43 and AR, was evaluated qualitatively in
at least 20 serial sections from each experimental group.
The cells were considered immunopositive if brown reaction
product was present in the cell nuclei, cytoplasm or appeared
as signal between the cells.
To evaluate the intensity of immunohistochemical reac-
tion quantitatively, digital images of prostate sections were
obtained using a Nikon DS-Fi2 Camera mounted on a Nikon
Eclipse Ni microscope (Nikon Co.). Images were captured
using a ×10 ocular and a ×20 objective. Image processing
andanalyseswereperformedusingthepublicdomainImageJ
s o ft w a r e( N a t i o n a lI n s t i t u t eo fH e a l t h ,B e t h e s d a ,M D ,U S A ) .
The intensity of the immunohistochemical reaction was
expressed as relative optical density (ROD) of diaminoben-
zidine brown reaction product and calculated using the
formula described by Smolen [26]. A total number of 40
prostate sections (𝑛=1 0 per group) were subjected to
i m a g ea n a l y s i sa n dr e s u l t so f1 0s e p a r a t em e a s u r e m e n t sw e r e
expressed as mean ± SD.
2.9. Statistical Analysis. Eachvariablewastestedbyusingthe
Shapiro-Wilk 𝑊-test for normality. Homogeneity of variance
was assessed with Levene’s test. Since the distribution of
the variables was normal and the values were homogeneous
in variance, all statistical analyses were performed using
one-way analysis of variance (ANOVA) followed by Tukey’s
post hoc comparison test to determine which values differed
significantly from controls. The analysis was made using Sta-
tistica 10 software (StatSoft Inc., Tulsa, OK, USA). Data were
presented as mean ± SD. Data were considered statistically
significant at 𝑃 < 0.05.
3. Results
3.1. Histology of the Prostates of Control and Flutamide-
Exposed Boars. The prostate structure in control boars pre-
sentedaciniwithsimplecylindricalepitheliumandfibromus-
cular stroma (asterisks) (Figure 1(a)). The secretory epithe-
lium lining the prostatic acini was composed of a single
layer of secretory cells (arrows) and a discontinuous layer
of relatively few basal cells (short arrows). In GD20 and
PD2 animals, reduction of acini size was observed (Figures
1(b) and 1(c)). Morphometric analysis revealed decrease of
luminal compartment (𝑃 < 0.01), whereas epithelium
height was unaltered when compared with the controls
(Table 1). In the stroma, inflammatory foci were observed
(white asterisks) (Figures 1(b) and 1(c)). In PD90 group
dysplastic areas with variation in cell size and shape were
occasionally observed (Figure 1(d),i n s e r t ) .I ns o m ea r e a s ,
the epithelium had become thicker with agglomerated nuclei
(arrows); however, no statistically significant differences in
epithelialheightwerefoundwhencomparedtocontrolmales
(Table 1).
3.2.LocalizationofARandCx43intheProstatesofFlutamide-
Treated Boars. ImmunostainingforARwaslocalizedtoboth
epithelial and stromal compartments of control and
flutamide-exposed pigs (Figures 1(e)–1(h)). In the glandular
epithelium of control pigs, the nuclei of secretory cells were
strongly stained (arrows), whereas basal cells exhibited
weaker signal(shortarrows).In thestroma,immunostaining
of variable intensity was detected (asterisks) (Figure 1(e)).
The positive staining was also found in smooth muscle cells
surrounding blood vessels (not shown). In the prostaticBioMed Research International 5
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Figure1:MorphologyandimmunohistochemicallocalizationofARandCx43inprostatesofcontrolandflutamide-exposedboars.Scalebars
represent 20𝜇m. ((a)–(d)) Morphology of the prostates. Prostatic tissue of control boars composed of fibromuscular stroma (asterisks) and
acini lined with the epithelium containing basal (short arrows) and secretory cells (arrows) (a). Note, decreased size of luminal compartment
((b),(c)) andinflammatoryfociin thestromain GD20and PD2animals (whiteasterisks)((b),insert in (c)).In PD90grouphyperplastic and
dysplastic epithelial alterations (insert in (d)) are visible (d). ((e)–(h)) Immunohistochemical localization of AR. Typical distribution of AR
to the nuclei of secretory (arrows), basal (short arrows), and stromal cells (asterisks) in the control group (e). Decreased staining intensity in
the epithelium (arrows) and stroma (asterisks) of GD20, PD2 ((f), (g)) and to the lesser extent in PD90 boars ((h)). Note, immunonegative
nuclei of stromal cells ((f), (g)) and cytoplasmic staining in some epithelial cells (insert in (g)) of GD20 and PD2 males. No signal was
detected when anti-AR antibody was substituted by normal goat serum (insert in (e)). ((i)–(l)) Immunohistochemical localization of Cx43.
The staining localized at the base of the epithelium and occasionally in the stroma of control prostates (i). Increased number and intensity of
the immunopositive foci in flutamide-exposed pigs ((j), (k), (l)). Note the staining dispersed in the cytoplasm of secretory cells of GD20 and
PD2 boars ((j), (k), insert in (k)). No signal was detected when anti-Cx43 antibody was substituted by normal goat serum (insert in (i)).6 BioMed Research International
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Figure 2: Quantitative analysis of immunohistochemical staining for AR and Cx43. Histograms of AR (a) and Cx43 (b) staining intensities
expressed as relative optical density (ROD) of diaminobenzidine brown reaction products. Data expressed as mean ± SD. Significant
differences from control values are denoted as
∗𝑃 < 0.05,
∗∗𝑃 < 0.01,a n d
∗∗∗𝑃 < 0.001.
epithelium of GD20 and PD2 groups, the staining pattern
presented heterogeneous but clearly less intense reaction
(arrows) in comparison to the control group. In some
epithelial cells a redistribution of AR from the nuclei to the
cytoplasm was observed (Figure 1(f),i n s e r ti nFigure 1(g)),
whereas most stromal cells were negative (asterisks)
(Figure 1). In PD90 boars the staining pattern was similar
to that of control animals, but the intensity of the staining
was slightly reduced (Figure 1(h)). Quantitative evaluation
of the intensity of immunohistochemical staining, expressed
as relative optical density (ROD), indicated the most pro-
nounced decrease of AR immunostaining in PD2 pigs
(𝑃 < 0.001)( Figure 2(a)).
I nc o n t r o lb o a r si m m u n o h i s t o c h e m i c a la n a l y s i sr e v e a l e d
the presence of Cx43-positive cells predominantlyat the base
oftheglandularepithelium,correspondingtothelocalization
o fb a s a le p i t h e l i a lc e l l s( Figure 1(i)). Cx43 signal appeared
as lines or clusters within the border between epithelial
andstromalcompartment(shortarrows).Cx43-positivecells
were also sparsely distributed within the stromal tissue
(asterisks).Exposureofmalepigstoflutamideclearlyaffected
Cx43 immunoexpression in adult prostate. Number of Cx43-
positive foci and intensity of the staining increased in these
animals, as demonstrated by quantitative analysis (𝑃 < 0.05;
𝑃 < 0.01)( Figure 2(b)). Moreover, in GD20 and PD2 groups
cytoplasmicstainingappearedinsomeepithelialcellsofpros-
tatic acini (arrows), which was not present in control boars
(Figures 1(j) and 1(k)). In PD90 males distribution pattern of
Cx43 was similar to that of control pigs, but immunopositive
foci were more numerous (Figure 1(l)).
Inthenegativecontroltissuesectionsnoimmunopositive
signalwasfoundwhentheincubationwasperformedwithout
the respective primary antibody (insert in Figures 1(e) and
1(i)).
3.3. Expression of mRNA and Protein for AR and Cx43
in the Prostates of Flutamide-Treated Boars. The expression
of mRNA for AR and Cx43 in prostates of control and
flutamide-exposed boars was assessed using the RT-PCR
technique. Electrophoresis revealed PCR-amplified products
of the predicted sizes: 242bp for AR, 232bp for Cx43, and
220bp for GAPDH (Figures 3(a) and 3(c)). To determine the
effect of flutamide on the expression of AR and Cx43 at the
mRNAlevel,real-timeRT-PCRanalysiswasperformed(Fig-
ure3).Theanalysisrevealedstatisticallysignificantchangesin
AR mRNA levels in all flutamide-exposed groups, reaching
about 2-fold decrease in mRNA expression compared with
the control group (𝑃 < 0.01)( Figure 3(a)). In contrast, Cx43
mRNAs were upregulated following flutamide treatment,
most markedly in PD2 and PD90 pigs (𝑃 < 0.001)( F i g -
ure 3(c)). No amplification was observed in all no-template
and no-RT control analyses, indicating the specificity of the
assays for mRNA.
Western blot analysis was performed to assess changes
in the level of AR and Cx43 protein expression following
flutamide exposure (Figures 3(b) and 3(d)). Immunode-
tectable AR and Cx43 proteins were observed as single bands
near the 110kDa and 43kDa position, respectively, of the
SDS gel in prostate homogenates of the control boars and
thosetreatedwithflutamide.Densitometricanalysisrevealed
significant decrease of AR expression in GD20 and PD2
groups (𝑃 < 0.05)( Figure 3(b)). In PD90 boars slight, not
statistically significant reduction of AR protein level was
found. Connexin 43 protein expression was increased in all
flutamide-exposed groups; however, the most distinct effect
was found in PD2 and PD90 males (𝑃 < 0.01)( Figure 3(d)).
3.4. Apoptosis and Proliferation in the Prostates of Flutamide-
Treated Boars. To further investigate the effect of androgenBioMed Research International 7
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Figure 3: Androgen receptor and Cx43 mRNAs and protein expression in prostates of control and flutamide-exposed boars. ((a), (c))
Androgen receptor and Cx43 mRNAs expression. As an intrinsic control, the GAPDH mRNA level was measured in the samples.
Representative gels electrophoresis of qualitative expression of AR (a), Cx43 (c) and GAPDH mRNAs. Line N1—negative control without
cDNA template, line N2—negative control without reverse transcribed RNA. Relative expression of mRNA for AR (a) and Cx43 (c)
determined using real-time RT-PCR analysis. Relative quantification (RQ) is expressed as means ± SD. Significant differences from control
values are denoted as
∗𝑃 < 0.05,
∗∗𝑃 < 0.01,a n d
∗∗∗𝑃 < 0.001. ((b), (d)) Androgen receptor and Cx43 protein expression. Representative
immunoblotsforAR(b)andCx43(d).Actinwasusedasaloadingcontrol,andeachsetofshownactinimmunoblotscorrespondstothetarget
protein that was investigated within a given panel. The relative level of AR (b) and Cx43 (d) protein normalized against its corresponding
𝗽-actin. Data obtained from three separate analyses is expressed as mean ± SD. Significant differences from control values are denoted as
∗𝑃 < 0.05,
∗∗𝑃 < 0.01,a n d
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Figure 4: Proliferating nuclear antigen (PCNA) and caspase 3 protein expression in prostates of control and flutamide-exposed boars. (a)
Immunofluorescent detection of PCNA in control prostate section (white arrows). Nuclei were counterstained with DAPI (blue). Scale bar
represents 20𝜇m ((b), (c)). Representative immunoblots for PCNA (b) and caspase 3 (c). The band at 32kDa represents inactive proenzyme
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shown actin immunoblots corresponds to the target protein that was investigated within a given panel. The relative level of PCNA (b) and
cleaved caspase 3 (c) protein normalized against its corresponding 𝗽-actin. Data obtained from three separate analyses is expressed as mean
± SD. Significant differences from control values are denoted as
∗𝑃 < 0.05,
∗∗𝑃 < 0.01,a n d
∗∗∗𝑃 < 0.001.
signaling disruption, apoptosis, and proliferation of prostatic
cells of control and flutamide-exposed males were deter-
mined using proliferating cell nuclear antigen (PCNA) as a
proliferation marker and cleaved caspase 3 as an apoptotic
marker. As the positive control a prostatic tissue from
castrated pigs was included.
Proliferatingcellnuclearantigenisanauxiliaryproteinof
DNA polymerase delta involved in the control of eukaryotic
DNAreplication;therefore,itsexpressionlevelreflectsprolif-
erative activity of a tissue [27]. Proliferating cell nuclear anti-
gen expression was visualized by immunofluorescence (Fig-
ure 4(a))a n dc o n fi rm e db yW e s t e rnb l o t t i n g( Figure 4(b)). A
single band at approximately34kDacorrespondingto PCNA
protein was detected in prostate homogenates of control and
flutamide-treated pigs (Figure 4(b)). In GD20 and PD2 pro-
statesreductioninPCNAproteinexpressionwasfound;how-
ever, the effect was statistically significant only in PD2 group
(𝑃 < 0.05). Treatment with flutamide during prepubertal
period (PD90) results in a slight, not significant increase in
PCNA level. In the prostates of adult castrated boars about
50% decrease of PCNA expression was observed (𝑃 < 0.01)
(Figure 4(b)).
Proteolytic cleavage of procaspase 3 occurs to generate
an active 17–19kDa caspase 3 fragments (cleaved caspase 3),
which target key modulators of the apoptotic pathway [28].
Using Western blot technique both forms of caspase 3 were
detected in prostate homogenates of controls and flutamide-
exposedboars(Figure 4(c)). The upper band at approximately
32kDa corresponds to the procaspase 3, whereas lower band
at17kDacorrespondstothecleavedcaspase3.Densitometric
analysis revealed increase of cleaved caspase-3 level in the
prostates of GD20 and PD2 pigs (𝑃 < 0.05), whereas in
PD90 males no obvious changes were found when compared
to the controls. In the prostates of castrated boars 3.5-fold
increase of the caspase 3 cleavage was detected (𝑃 < 0.001)
(Figure 4(c)).
4. Discussion
In the present study we used flutamide, pure androgen
receptor antagonist, to block androgen action transiently
during the period of sex differentiation (GD20) as well as
duringneonatal(PD2) and prepubertaldevelopment (PD90)
o ft h eb o a r .W ef o u n dt h a td i s r u p t i o no fa n d r o g e ns i g n a l i n g
during these periods may affect functioning of prostatic
cells in adult animals by altering the AR and Cx43 genes
expression as well as proliferation and apoptosis rates.
Histological analysis of prostates of flutamide-exposed
males showed no significant changes in their gross appear-
ance when compared to the prostates of vehicle-treated con-
trols. However, the presence of inflammatory foci and reduc-
tion of acini size were observed in GD20 and PD2 males.
Prostatic inflammation is often detected in adult prostate
as a response after treatment with different antiandrogenic
chemicals during early development, such as vinclozolin and
phthalates [29, 30]. Although precise mechanisms involved
in the induction of inflammatory changes following devel-
opmental exposures to endocrine disruptors are still not
fully understood, multiple studies indicate that sex hormone
imbalance may be the key factor in this process [31, 32].BioMed Research International 9
Estrogens are considered as proinflammatory hormones,
whereastestosteroneexertsanti-inflammatoryactiononpro-
static tissue [33]; thus, inflammatory foci in GD20 and PD2
boars are likely to result from decreased androgen: estrogen
ratio described previously [34]. Altered action of sex hor-
mones could also contribute to changes in prostatic acini
morphology. Acini of GD20 and even more evident of PD2
males were usually smaller than these of control males,
becauseofthereductionoftheluminalcompartment.Similar
effect was reported in ventral prostates of rats exposed peri-
natallytodi-n-butyl-phthalate(DBP),anenvironmentalanti-
androgenic chemical as well as in prostates of estrogenized
castrated Mongolian gerbils [30, 35]. A common cause of
reduced luminal area is altered secretory activity of epithelial
cells. This activity is directly regulated by AR activation in
the prostatic epithelium [36]. In the present study reduced
expression of AR and its delocalization to the cytoplasm in
somecellsofprostaticepitheliumofGD20andPD2boarswas
found. Cytoplasmic localization of AR may indicate receptor
degradation and/or may be related to the reduced bioavail-
ability of testosterone [37, 38]. Taken together, dysfunction
of epithelial AR in flutamide-exposed pigs may be one of the
triggermechanismscontributingtothereductionofprostatic
acinar lumen and size.
Interestingly, in stromal cells of GD20 and PD2 males
we found almost total loss of AR immunostaining. In fetal
andperinataldevelopmentmesenchymalstromalcellsarethe
main target for androgen action in the prostate, since epithe-
lial cells are AR-negative until early postnatal period [39].
Therefore, it can be hypothesized that prenatal and neonatal
exposuretoflutamideoriginallyaffectsstromalcellfunctions,
alteringtheirabilitytorespondtoandrogensignalinginadult
male. This in turn may be the reason of disturbed prostatic
epithelium functions in adulthood. Importance of androgen
action in the stroma on normal structure and function
of glandular epithelium was demonstrated by experiments
performed on urogenital tissue recombinants from wild-type
andandrogen-insensitivemice[40].Theauthorsshowedthat
many androgenic effects on prostatic epithelial development
do not require epithelial AR and these effects are elicited
by the paracrine action of AR-positive mesenchymal stroma.
These observations were supported by recent studies on
t i s s u e - s e l e c t i v ek n o c k o u tm i c ew i t ht h eA Rg e n ed e l e t e di n
stromal smooth muscle cells or stromal fibroblasts [41, 42].
Interestingly, in both knockout models reduced epithelial
cell proliferation was described. Therefore, it is likely that
decreased proliferation, as reflected by reduced expression of
PCNA, found in prostates of PD2 boars and, in lesser extent,
in GD20 boars is directly associated with altered expression
of AR in the stromal tissue. Indeed, Perry and Tindall
[43] showed that in human prostate cell line the antiandro-
gen, casodex, inhibited the mibolerone-stimulated increase
in PCNA expression, suggesting that the androgenic induc-
tion of PCNA is mediated through the AR.
Caspase 3 activation is considered as an indicator of
apoptosis induction, because different upstream pathways
leadingtoapoptosisdependoncaspase3cleavage[44].Thus,
in the present study apoptosis was assessed by evaluating
the level of cleaved (active) form of caspase 3 in prostate
homogenates. Since it is known that castration induces
apoptosis of prostatic epithelial cells, to validate our results
we included an analysis of cleaved caspase 3 expression in
prostates of castrated pigs that served as a positive control.
Indeed, the level of cleaved caspase 3 in prostates of castrated
boars appeared to be 3.5-fold higher when compared to
the vehicle-treated control males. In the prostates of GD20
and PD2 boars much less marked, but still statistically
significant increase in the apoptosis activation was detected.
Th i si si nl i n ew i t he a r l i e rs t u d i e ss h o w i n gt h a tt h ef e t a l
hormonal disruption induced by antiandrogens, such as
flutamide, vinclozolin, and phthalates, gives rise to a long-
term apoptosis in reproductive organs (testis, epididymis) in
theadultmale[45,46].Increasedapoptosiswasdetectedalso
in the testes and epididymides of adult boars treated with
flutamide during prenatal and neonatal development [9, 10].
Th e r e f o r e ,o u rd a tas u p po rtth ec o n c e p to ff e tala n dpe ri n a tal
programming of adult cell apoptosis in reproductive tissues.
Another possible explanation is that decreased testosterone
levelandreducedexpressionofARinprostatesofadultGD20
and PD2 males directly induce caspase cleavage, activating
cell death pathways.
In PD90 boars the effects of flutamide treatment on
prostate morphology and AR expression were less pro-
nounced than those observed in GD20 or PD2 males. Pro-
static acini were well developed with the lumen comparable
to that of control pigs and there was no evidence of inflam-
matory changes. However, glandular epithelium was more
folded with occasionally observed hyperplastic or dysplastic
changes. Although AR mRNA level was clearly downregu-
lated, the reduction of AR protein expression in PD90 males
was less evident particularlyin thestroma.Theinconsistency
observed between PCR and Western blot analysis of AR
m a ys u g g e s tt h a ts t a b i l i t yo fA Rm R N Ao rr a t eo fm e t a -
bolic degradation of AR protein in the prostate of these
animals was altered [47, 48].
Moreover, in PD90 boars no marked changes in PCNA
and cleaved caspase 3 expression were detected. This is in
line with the results by G´ omez et al. [49], who showed that
chemicalcastrationinducedbycyproteroneacetatetreatment
during prepubertal period did not affect cell proliferation
and apoptosis. Therefore, it is likely that effects of androgenic
blockade during prepubertal period on cell proliferation and
apoptosis are transient and are not maintained in adult boar
prostate.However ,itcannotbeexcludedthatandrogenaction
during prepubertal period is not necessary to control cell
proliferation and to protect prostatic cells from apoptosis.
According to our knowledge Cx43 expression and dis-
tribution in the boar prostate have not been described
yet. We used real-time RT-PCR and Western blot meth-
ods to reveal the presence of Cx43 mRNA and protein
in prostate homogenates of adult intact boars. Immuno-
histochemical analysis demonstrated that in boar prostate
Cx43 was localized predominantly in the basal region of
glandular epithelium, similarly as it was observed in rat
[14]. In contrary to punctuate signal dispersed within the
secretory cell layer in guinea pig and stallion, no staining
was detected in the secretory cells of prostatic acini of the
boar, suggesting species-dependent distribution of Cx43 in10 BioMed Research International
prostatic epithelium [50, 51].Itisalsopossiblethatinporcine
prostatic epithelium the amount of Cx43 in secretory cells
is below the detection sensitivity of immunohistochemical
methods used herein.
Following prenatal and postnatal exposure to flutamide,
Cx43 mRNA and protein levels markedly increased, pre-
dominantly in PD2 and PD90 males. Increased intensity of
Cx43 staining and increased number of Cx43-positive foci
werealsoevidentinimmunohistochemicalsections.Previous
studies on the rat model showed that Cx43 expression is
directly regulated by testosterone in adult males [52]. The
authors demonstrated that androgen deprivation induced
by castration upregulated Cx43 mRNA and protein expres-
s i o ni nt h ep r o s t a t e ,w h i l ea n d r o g e nr e p l a c e m e n tr e s u l t e d
in restoration of Cx43 level to the values characteristic
for normal (sham-castrated) rats. It is likely therefore that
alterations of Cx43 expression found in our study are related
to androgen signaling disruption due to AR downregulation
and/or decreased testosterone concentration in adult boars
following developmental exposure to flutamide. Increased
testosterone aromatization to estradiol in flutamide-treated
boars[34]couldalsocontributetoenhancedCx43expression
in prostatic cells as shown by Carruba et al. [53].
Interestingly, in GD20 and PD2 males diffused stain-
i n ga p p e a r e di nt h ec y t o p l a s mo fs e c r e t o r ye p i t h e l i a lc e l l s ,
whereas in the controls they were immunonegative, indicat-
ing altered phenotype of secretory cells in flutamide-exposed
groups. Habermann et al. [14] demonstrated that differentia-
tion of prostatic epithelium during postnatal development is
associatedwithprogressivelossofCx43expression.Thus,the
presence of Cx43 in secretory epithelial cells of boars treated
with flutamide during fetal and neonatal period may reflect
altered differentiation of prostatic epithelium.
However, it cannot be excluded that local inflammatory
changes found in the prostates of GD20 and PD2 boars
contribute to the alterations in Cx43 expression. The rela-
tionship between Cx43 expression and inflammation was
demonstrated to date in several organs, including liver, kid-
ney, testis, epididymis, and brain [10, 54–57]. Furthermore,
it was established that proinflammatory cytokines, such as
tumornecrosisfactorandinterleukin-1,modulatethecell-to-
cell communication and connexin 43 levels in vitro [58].
It is worth noting that Cx43 and AR alterations in the
prostates demonstrated in the present study are different
than alterationsrecentlyobserved in testes and epididymides
of flutamide-exposed boars [9, 10]. It is likely, therefore,
that Cx43 and AR genes expression during development is
differentially regulated by androgens in different tissues of
porcine male reproductive system.
The question arises as to the causal link between the
transient developmental exposure to flutamide and the adult
prostate disorders. Several studies indicate that upstream
mechanisms leading to the long-term alterations observed
in adult prostate may be related to the epigenetic changes,
such as DNA methylation and histone modifications. It was
reported that changes in methylation states of several genes
induced by exposure to antiandrogen vinclozolin during
the period of sex determination are correlated with disease
state in numerous organs of adult rats, including prostate
[5, 59]. The role of epigenetic factors was also demonstrated
by Ho et al. [60], who found altered methylation pattern
of phosphodiesterase type 4 in adult rat prostate following
neonataltreatmentwithestradiol.ForCx43,epigeneticeffect
of different toxicants in the liver has also been documented
[61]. In prostate cancer cells, Hernandez et al. [62]f o u n dth a t
Cx43 was induced as a result of hyperacetylation of histones
H4 surroundingthe AP-1- and Sp1-responsive gene elements.
It was also established that CpG methylation and histone
acetylation may play important roles in the regulation of the
AR, especially in prostate cancer cells [63, 64]. Importantly,
recent studies indicate that prostate stem/progenitor cells
may undergo life-long reprogramming, as a consequence of
developmental exposures to endocrine disrupting chemicals
[65].
Finally,therearetwolimitationsthatneedtobetakeninto
account when considering the study and its contributions.
The first is relatively small number of experimental animals
usedinthestudy.Owingtothesignificantphysiological,bio-
chemical, anatomical, and genomic similarities between pigs
and humans, the pig provides a uniquely relevant biomedical
model for human, having a distinct advantage over rodents
[66]. The expense of experiments, performed on pigs, did
not allow to conduct studies on large group of animals.
However, in the present study the responses of the individual
animalstoexperimentalconditionswithineachexperimental
group were very homogeneous. Furthermore, to validate the
r esul tseachanalysiswasperformedintriplica teusingseveral
complementary techniques.
Second limitation is the assessment of the effects of flu-
tamide exposure on the prostate only at adulthood. It should
be stressed, however, that in the previous studies from this
laboratory no changes in the testes of neonatal pigs after fetal
exposure to flutamide were found, whereas in prepubertal
malesseminiferoustubuleswereaffectedoccasionally[18,19].
The most severe alterations were clearly found in adult testes
[9] .Th o s eo b s e r v a t i o n ss u g g e s tt h a tm o s te ff e c t so ft r a n s i e n t
developmental exposure to flutamide on pig testis are not
revealed until adulthood. Thus, we anticipate that such long-
term effect may also occur in the prostate. To test directly
short-term effects of flutamide action, in vitro studies have
recently been undertaken.
Altogether the results presented herein indicate that in
boar androgen action during early fetal and neonatal periods
plays a fundamental role in the maintenance of normal
phenotype and functions of prostatic cells at adulthood.
Downstream effects of the blockade of AR activation in these
criticalperiodsincludechangesintheexpressionandcellular
localization of AR and Cx43, as well as alterations of prolif-
eration and apoptosis ratio. Moreover, we demonstrated that
modulation of Cx43 expression in the prostate could serve
as a sensitive marker of hormonal disruption on different
developmental stages, since deregulation of this protein was
found in all experimental groups.
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